These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9922770)

  • 21. [Simultaneous radiochemotherapy].
    Dunst J; Sauer R
    Strahlenther Onkol; 1993 Apr; 169(4):205-12. PubMed ID: 8488457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life and treatment related toxicity in 335 patients with locally advanced cervical carcinoma treated by two chemoradiation regimens.
    Nagy V; Todor N; Coza O; Ordeanu C; Ghilezan N
    J BUON; 2007; 12(3):389-94. PubMed ID: 17918294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicities in RTOG combined-modality trials for inoperable non-small-cell lung cancer.
    Byhardt RW
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):116-20. PubMed ID: 10550835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer: a randomised phase II EORTC trial.
    Bartelink H; Van den Bogaert W; Horiot JC; Jager J; van Glabbeke M
    Eur J Cancer; 2002 Mar; 38(5):667-73. PubMed ID: 11916549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoradiotherapy of human tumors: novel approaches from nanomedicine.
    Werner ME; Foote MB; Wang AZ
    Curr Pharm Des; 2012; 18(19):2830-7. PubMed ID: 22390766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiochemotherapy in head and neck cancer.
    Merlano M; Marchetti G
    Cancer Treat Rev; 2003 Aug; 29(4):291-6. PubMed ID: 12927569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current methods of chemoradiotherapy for locally advanced cervical cancer. Options for reduction of side-effects].
    Póti Z; Mayer A
    Orv Hetil; 2013 May; 154(21):803-9. PubMed ID: 23692874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chemoradiotherapy. Therapeutic indications: the doctor's point of view].
    Natale D; Orlando D
    Suppl Tumori; 2004; 3(4):S123-4. PubMed ID: 15206236
    [No Abstract]   [Full Text] [Related]  

  • 30. Recent advances in combined modality therapy.
    Mierzwa ML; Nyati MK; Morgan MA; Lawrence TS
    Oncologist; 2010; 15(4):372-81. PubMed ID: 20413642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.
    Dunst J; Haensgen G
    Strahlenther Onkol; 2001 Dec; 177(12):635-40. PubMed ID: 11789401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can the therapeutic gain of radiotherapy be increased by concurrent administration of Asian botanicals?
    Sagar SM
    Integr Cancer Ther; 2010 Mar; 9(1):5-13. PubMed ID: 20042406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems.
    Denis F; Garaud P; Bardet E; Alfonsi M; Sire C; Germain T; Bergerot P; Rhein B; Tortochaux J; Oudinot P; Calais G
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):93-8. PubMed ID: 12504040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in radiosensitization.
    Lawrence TS
    Clin Adv Hematol Oncol; 2004 Sep; 2(9):575-7. PubMed ID: 16163239
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer.
    Wong SJ; Moughan J; Meropol NJ; Anne PR; Kachnic LA; Rashid A; Watson JC; Mitchell EP; Pollock J; Lee RJ; Haddock M; Erickson BA; Willett CG
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):116-23. PubMed ID: 25446610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current studies of combined radiotherapy-hormone therapy in localized and locally advanced prostatic cancers].
    Bolla M; Artignan X; Chirpaz E; Balosso J; Descotes JL
    Cancer Radiother; 1998 Dec; 2(6):783-6. PubMed ID: 9922789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent Neoadjuvant Chemotherapy and Radiation Therapy in Locally Advanced Breast Cancer.
    Brackstone M; Palma D; Tuck AB; Scott L; Potvin K; Vandenberg T; Perera F; D'Souza D; Taves D; Kornecki A; Muscedere G; Chambers AF
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):769-776. PubMed ID: 28870785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Locoregional breast radiotherapy and concurrent treatment with trastuzumab].
    Jacob J; Kirova YM
    Bull Cancer; 2014 Jan; 101(1):40-51. PubMed ID: 24445735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modification of radiosensitivity following chemotherapy exposure: potential implications for combined-modality therapy.
    Britten RA
    Cancer Treat Res; 2002; 112():285-303. PubMed ID: 12481721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.